These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 27499693

  • 1. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
    Xiao C, Zhong L, Shan Z, Xu T, Gan L, Song H, Yang R, Li L, Liu B.
    Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
    [Abstract] [Full Text] [Related]

  • 2. NLS-RARα promotes proliferation and inhibits differentiation in HL-60 cells.
    Hu XX, Zhong L, Zhang X, Gao YM, Liu BZ.
    Int J Med Sci; 2014; 11(3):247-54. PubMed ID: 24516348
    [Abstract] [Full Text] [Related]

  • 3. NLS‑RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway.
    Song H, Li L, Zhong L, Yang R, Jiang K, Yang X, Liu B.
    Mol Med Rep; 2016 Dec; 14(6):5495-5500. PubMed ID: 27840989
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
    Yao S, Zhong L, Chen M, Zhao Y, Li L, Liu L, Xu T, Xiao C, Gan L, Shan Z, Liu B.
    Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
    [Abstract] [Full Text] [Related]

  • 5. [All-trans retinoic acid promotes differentiation of human leukemia cells by degrading NLS-RARα].
    Li J, Liu B, Ye J, Xiong L, Yu L, Zhong P, Yuan Z, Liu D, Yao J, Liu J, Zhong L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1082-1087. PubMed ID: 31894006
    [Abstract] [Full Text] [Related]

  • 6. Activation of G0S2 is coordinated by recruitment of PML/RARα and C/EBPε to its promoter during ATRA-induced APL differentiation.
    Zhang F, Zhu YL, Deng WL, Zhu J, Zhang J.
    J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
    [Abstract] [Full Text] [Related]

  • 7. NLS-RARα blocks cell differentiation by inhibiting the retinoic acid signalling pathway.
    Li J, Zhong L, Ye J, Xiong L, Yu L, Dan W, Zhong P, Yuan Z, Liu D, Yao J, Liu J, Liu B.
    Biochem Biophys Res Commun; 2020 Jul 23; 528(2):276-284. PubMed ID: 32475642
    [Abstract] [Full Text] [Related]

  • 8. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E.
    Differentiation; 1997 Aug 23; 61(5):321-31. PubMed ID: 9342843
    [Abstract] [Full Text] [Related]

  • 9. Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia.
    Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T.
    Leukemia; 1997 Nov 23; 11(11):1950-6. PubMed ID: 9369431
    [Abstract] [Full Text] [Related]

  • 10. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
    Coltella N, Valsecchi R, Ponente M, Ponzoni M, Bernardi R.
    Clin Cancer Res; 2015 Aug 15; 21(16):3685-94. PubMed ID: 25931453
    [Abstract] [Full Text] [Related]

  • 11. Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies.
    Wu D, Shao K, Zhou Q, Sun J, Wang Z, Yan F, Liu T, Wu X, Ye B, Huang H, Zhou Y.
    Cell Physiol Biochem; 2018 Aug 15; 48(6):2286-2301. PubMed ID: 30114705
    [Abstract] [Full Text] [Related]

  • 12. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
    Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P.
    Blood; 1998 Sep 01; 92(5):1758-67. PubMed ID: 9716606
    [Abstract] [Full Text] [Related]

  • 13. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L, Xiao H, Zhang X, Liao W, Fu S, Huang H.
    Int J Oncol; 2015 Nov 01; 47(5):1685-95. PubMed ID: 26397153
    [Abstract] [Full Text] [Related]

  • 14. NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo.
    Xiong L, Zhong L, Yu L, Dan W, Ye J, Li J, Liu D, Yuan Z, Yao J, Zhong P, Liu J, Liu B.
    Cell Signal; 2020 Jan 01; 65():109431. PubMed ID: 31654721
    [Abstract] [Full Text] [Related]

  • 15. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D, Hartmann JU, Wurm AA, Gerloff D, Katzerke C, Verga Falzacappa MV, Pelicci PG, Müller-Tidow C, Tenen DG, Niederwieser D, Behre G.
    Cancer Res; 2015 Aug 15; 75(16):3411-24. PubMed ID: 26041820
    [Abstract] [Full Text] [Related]

  • 16. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
    Gianni M, Fratelli M, Bolis M, Kurosaki M, Zanetti A, Paroni G, Rambaldi A, Borleri G, Rochette-Egly C, Terao M, Garattini E.
    Oncotarget; 2017 Jun 06; 8(23):37041-37060. PubMed ID: 27419624
    [Abstract] [Full Text] [Related]

  • 17. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH, Noh YH, Lee YS, Ahn MJ.
    Biochem Biophys Res Commun; 2002 Sep 06; 296(5):1125-33. PubMed ID: 12207890
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
    Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K.
    Blood; 1998 Jul 15; 92(2):374-82. PubMed ID: 9657734
    [Abstract] [Full Text] [Related]

  • 19. Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.
    Côté S, Rosenauer A, Bianchini A, Seiter K, Vandewiele J, Nervi C, Miller WH.
    Blood; 2002 Oct 01; 100(7):2586-96. PubMed ID: 12239173
    [Abstract] [Full Text] [Related]

  • 20. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y, Xia L, Lu M, Waxman S.
    Oncogene; 2003 Jun 26; 22(26):4083-91. PubMed ID: 12821942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.